Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,045 | 53,360 | 57,782 | 61,813 | 20,440 |
| Receivables | 2,913 | 1,920 | 2,096 | 1,354 | 1,698 |
| Other current assets | 0 | 0 | 0 | 0 | 407 |
| TOTAL | $48,958 | $55,280 | $59,878 | $63,167 | $22,545 |
| Non-Current Assets | |||||
| PPE Net | 6,273 | 5,914 | 5,404 | 4,506 | 3,763 |
| Other Non-Current Assets | 657 | 626 | 544 | 464 | 402 |
| TOTAL | $6,930 | $6,540 | $5,948 | $4,970 | $4,165 |
| Total Assets | $55,888 | $61,820 | $65,826 | $68,137 | $26,710 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,399 | 4,340 | 4,205 | 3,762 | 3,613 |
| TOTAL | $4,399 | $4,340 | $4,205 | $3,762 | $3,613 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 994 | 967 | 872 | 690 | 629 |
| TOTAL | $994 | $967 | $872 | $690 | $629 |
| Total Liabilities | $5,393 | $5,307 | $5,077 | $4,452 | $4,242 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,593 | 7,593 | 7,588 | 7,586 | 7,569 |
| Common Shares | 76 | 76 | 76 | 76 | 66 |
| Retained earnings | -58,831 | -52,335 | -48,106 | -52,596 | -37,862 |
| TOTAL | $50,495 | $56,513 | $60,749 | $63,685 | $22,468 |
| Total Liabilities And Equity | $55,888 | $61,820 | $65,826 | $68,137 | $26,710 |